KOL Identification and Mapping

Because of our in-house panel, we are the most trusted partner in identifying, mapping, and engaging KOLs in the life sciences and healthcare sectors.

Get Started

Industries We Serve

BFSI (Banking, Financial Services, and Insurance)

Capital Markets

TMT (Telecom, Media & Entertainment, & Technology)

Other Industries

Healthcare key Opinion Leaders

Because their recommendations on pharmaceuticals and devices are founded on solid research, key opinion leaders(KOL) are the perfect drivers for any healthcare product firm (drugs, gadgets, diagnostics).

At SGA, we work with our customers to find the kind of key opinion leader (KOL) to advise them on the best ways to network within their business. It can result in a more extensive disease environment within which the client’s treatment or technology must function.

What Difference Does

SGA Make with its KOL Mapping

Services for the Healthcare Industry?

SGA’s panel of KOLs spans more than 30 sub-specialties and 15 organizational levels, from chief executive officers to senior managers and distributors. Our panelists provide invaluable insight into the market’s mood, perspective, and anticipations throughout a client’s product’s lifetime and clinical trials. Our bilingual analysts will facilitate communication with these key opinion leaders in both English- and non-English-speaking areas.

Why SGA

Industry Leader

SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.

12+ Languages

Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with the in-house capabilities of primary market research, financial research, data analytics, data engineering, IT, and ESG research and consulting, helps to present credible competitive information.

Who We Work With

Medical Devices

We support new product entries, competitive intelligence (CI), and market intelligence teams with relevant information.

Pharmaceuticals & Biopharma

We support pharma and biopharma market intelligence, strategy, sales, marketing, and R&D teams in developed and developing markets.

Mergers and Acquisition Analysis

We support M&A firms with product portfolio fitment analysis, patents and clinical trial data, pipeline analysis, and short listing of healthcare acquirer and acquire prospects.

Private Equity, Investment Banks, and Investor Community

We support financial firms with ad-hoc and white-labeled research comprising industry analysis, primary research, and CI intel from major markets.

Animal Health

We offer market intelligence on veterinary products and equipment and help mid-senior management with relevant data.

In Vitro Diagnostics

We track diagnostics kits, reagents, and equipment, which help marketing and sales teams with market penetration efforts. Our services are preferred by product managers and marketing leaders.

Life Sciences & Healthcare IT

We offer technology tracking services, market sizing and forecasting, and primary market research involving healthcare payers and providers and product launch information to life sciences & healthcare IT leaders of the world.

Life Sciences Consulting & Information Service Providers

We have run off-shored capability centers of ISPs, with a record of tracking >5,000 pharmaceutical companies and supporting their onshore teams to track markets and create analyses.

Our Ins(AI)ghts

Whitepaper

Leveraging AI and Machine Learning for Data Quality Management

As organizations embrace digital transformation, the volume and value of data are growing exponentially. At SG Analytics, we help enterprises elevate their data quality management (DQM) practices by leveraging artificial intelligence (AI) and machine learning (ML). Our AI-powered solutions automate data cleansing, improve accuracy, and ensure consistency—enabling faster, more reliable decision-making. By embedding intelligence into DQM, businesses can reduce risk, optimize operations, and unlock the full potential of their data assets for sustained growth and competitive advantage.

BLOG

The Growing Role of Artificial Intelligence in the Media & Entertainment Industry

AI is helping the media and entertainment industry stakeholders by enhancing content creation, personalization, and operational efficiency. It powers tools like predictive analytics, chatbots, and recommendation systems, creating tailored user experiences and streamlining production. AI also enables immersive AR/VR content, targeted advertising, and real-time content moderation. It improves marketing strategies and helps manage media assets efficiently. As consumer demands evolve, AI continues to shape storytelling, drive innovation, and ensure content authenticity through deepfake detection. The future of media and entertainment is increasingly data-driven, interactive, and personalized, positioning AI as a transformative force across the industry’s entire value chain.

Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high-quality, white-labeled research coverage.

Let’s Talk